Dental Biomaterial Market is Forecasted to Reach a Value of US$ 2.7 Billion by 2034: Fact.MR

According to a recently published analysis by Fact.MR, a market research and competitive intelligence service, the global dental biomaterial market is expected to be worth $1.73 billion by 2024. Worldwide demand for dental biomaterials is expected to reach $2.7 billion by the end of 2034.

The growing usage of dental biomaterials to assist in tissue formation and repair damaged tissues is expected to be a major development factor in the global market. In recent years, various R&D activities have been carried out in biomaterials, which are used in dental treatment by many dental practitioners.

Get Free Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=9540

Market competitors are expected to offer a variety of biomaterials that will speed biological processes for the regeneration of lost dental tissues. Dental implants are expected to become more popular as people become more aware of the importance of oral hygiene and facial appearance.

Extensive R&D on dental biomaterials is expected to lead to advancements in oral care. However, the rising cost of dental procedures, combined with a scarcity of experienced medical staff and trained specialists across geographies, is expected to stifle market expansion.

Key Takeaway from Market Study

The global dental biomaterials market is expected to reach $1.73 billion by 2024.
Worldwide demand for dental biomaterials is expected to reach $2.7 billion by the end of 2034.
Between 2024 and 2034, global sales of dental biomaterials are expected to grow at a CAGR of 4.5%.
North America is expected to have 53.5% of the worldwide market share by 2034.
The Brazilian market is expected to grow at a CAGR of 5.8%, reaching US$ 87.1 million by the end of 2034.
Dental clinics are expected to account for 45.3% of the global market by 2034.

"Rising prevalence of dental disorders, increasing use of dental implants, and growing dental tourism are forecasted to drive sales of dental biomaterials," says a Fact.MR analyst.

𝐑𝐞𝐚𝐝 𝐌𝐨𝐫𝐞: https://www.factmr.com/report/dental-biomaterial-market

Key Market Players

Geistlich Pharma, Inc.,
3M Company,
Danaher Corporation,
Institut Straumann AG,
Dentsply Sirona,
Zimmer Biomet,
Royal DSM,
Medtronic PLC,
GC Corporation,
Ivovlar Vivadent AG,
Henry Schein, Inc.,
Keystone Dental, Inc.,
Mitsui Chemicals, Inc.,
Carpenter Technology Corporation,
Datum Dental Ltd.

Dental Clinics Accounting for Leading Market Share

Global demand for dental biomaterials in clinics is expected to grow at a CAGR of 4.3%, reaching a market value of US$ 1.22 billion by the end of 2034. This increased demand is linked to rising dental practice rates and expanding awareness about oral hygiene. Furthermore, the increasing prevalence of tooth problems among individuals is expected to drive demand for dental biomaterials in clinics.

Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=9540

More Valuable Insights on Offer

Fact.MR, in its new offering, presents an unbiased analysis of the dental biomaterial market, presenting historical demand data for 2018 to 2023 and forecast statistics for 2024 to 2034.

The study divulges essential insights into the market based on product type (dental membranes, dental bone graft substitutes, dental materials) and end user (hospitals, dental clinics, others), across six major regions of the world (North America, Europe, East Asia, Latin America, South Asia & Oceania, and MEA).

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com

𝐀𝐛𝐨𝐮𝐭 𝐅𝐚𝐜𝐭.𝐌𝐑

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.